Author:
Yin Jie,Xia Weiwei,Zhang Yue,Ding Guixia,Chen Lihong,Yang Guangrui,Huang Songming,Jia Zhanjun,Zhang Aihua
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference40 articles.
1. Li Z, Li Q, Wu J, Wang M, Yu J (2016) Artemisinin and its derivatives as a repurposing anticancer agent: what else do we need to do? Molecules 21:E1331
2. Park KH, Yoon YD, Han SB, Oh SJ, Yun J, Lee CW, Lee K, Park SK, Kim HM, Kang JS (2012) Artemisinin inhibits lipopolysaccharide-induced interferon-beta production in RAW 264.7 cells: implications on signal transducer and activator of transcription-1 signaling and nitric oxide production. Int Immunopharmacol 14:580–584
3. Wang Z, Hu W, Zhang JL, Wu XH, Zhou HJ (2012) Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity. FEBS Open Bio 2:103–112
4. Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, Li L, Tang B, Allen TD, Liu J (2014) Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis. Cancer Biol Ther 15:1479–1488
5. Liu W, Wang DW, Yu SY, Cao Y, Yang L, E XQ, Yao GJ, Bi ZJ (2015) The effect of dihydroartemisinin on the proliferation, metastasis and apoptosis of human osteosarcoma cells and its mechanism. J Biol Regul Homeost Agents 29:335–342
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献